ENZO BIOCHEM, INC. Proceeds from Common Stock Issued
ENZO BIOCHEM, INC. reported Proceeds from Common Stock Issued of $386.00 thousand for the 12-month period ending 2023-07-31, per its 10-K filed 2024-10-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-10-29
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for the quarter ending 2015-07-31 was $1.00K, a 99.95% decline year-over-year.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for the quarter ending 2015-04-30 was $1.35M, a 74.17% decline year-over-year.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for the quarter ending 2015-01-31 was $3.02M, a 17.93% increase year-over-year.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for the quarter ending 2014-10-31 was $2.32M, a 37.89% increase year-over-year.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for fiscal 2023 was $386.00K.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for fiscal 2015 was $6.69M, a 42.06% decline from fiscal 2014.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for fiscal 2014 was $11.54M, a 532.44% increase from fiscal 2013.
- ENZO BIOCHEM, INC. proceeds from issuance of common stock for fiscal 2013 was $1.82M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-07-31 | $386.00K 10-K · filed 2024-10-29 | |||
| 2015-07-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | $1.35M derived: sum of 2 quarters · filed 2017-09-27 | $4.37M derived: sum of 3 quarters · filed 2017-09-27 | $6.69M 10-K · filed 2017-09-27 |
| 2015-04-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-06-08 | $4.37M derived: sum of 2 quarters · filed 2016-06-08 | $6.69M 10-Q · filed 2016-06-08 | $8.77M derived: sum of 4 quarters · filed 2016-10-13 |
| 2015-01-31 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-03-09 | $5.34M 10-Q · filed 2016-03-09 | $7.43M derived: sum of 3 quarters · filed 2016-10-13 | $12.64M derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-10-31 | $2.32M 10-Q · filed 2015-12-08 | $4.41M derived: sum of 2 quarters · filed 2016-10-13 | $9.62M derived: sum of 3 quarters · filed 2016-10-13 | $12.18M derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-07-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $7.30M derived: sum of 2 quarters · filed 2016-10-13 | $9.86M derived: sum of 3 quarters · filed 2016-10-13 | $11.54M 10-K · filed 2016-10-13 |
| 2014-04-30 | $5.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-06-09 | $7.77M derived: sum of 2 quarters · filed 2015-06-09 | $9.46M 10-Q · filed 2015-06-09 | $11.28M derived: sum of 4 quarters · filed 2015-10-13 |
| 2014-01-31 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-03-12 | $4.24M 10-Q · filed 2015-03-12 | $6.07M derived: sum of 3 quarters · filed 2015-10-13 | |
| 2013-10-31 | $1.68M 10-Q · filed 2014-12-09 | $3.51M derived: sum of 2 quarters · filed 2015-10-13 | ||
| 2013-07-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $1.82M 10-K · filed 2015-10-13 | ||
| 2013-04-30 | $3.00K 10-Q · filed 2014-06-09 |